Anthera Pharmaceuticals Hits New 12-Month Low at $2.39 (ANTH)
Anthera Pharmaceuticals (NASDAQ:ANTH) reached a new 52-week low on Thursday , American Banking News reports. The company traded as low as $2.39 and last traded at $2.43, with a volume of 121,426 shares. The stock had previously closed at $2.58.
The stock has a 50-day moving average of $2.97 and a 200-day moving average of $3.07. The company’s market cap is $56.4 million.
Anthera Pharmaceuticals (NASDAQ:ANTH) last announced its earnings results on Monday, July 28th. The company reported ($0.34) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.49) by $0.15. On average, analysts predict that Anthera Pharmaceuticals will post $-1.58 earnings per share for the current fiscal year.
Anthera Pharmaceuticals, Inc (NASDAQ:ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with Analyst Ratings Network's FREE daily email newsletter.